1. Home
  2. NLSP vs ILAG Comparison

NLSP vs ILAG Comparison

Compare NLSP & ILAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • ILAG
  • Stock Information
  • Founded
  • NLSP 2015
  • ILAG 1981
  • Country
  • NLSP Switzerland
  • ILAG Hong Kong
  • Employees
  • NLSP N/A
  • ILAG N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • ILAG Office Equipment/Supplies/Services
  • Sector
  • NLSP Health Care
  • ILAG Consumer Discretionary
  • Exchange
  • NLSP Nasdaq
  • ILAG Nasdaq
  • Market Cap
  • NLSP 12.4M
  • ILAG 9.4M
  • IPO Year
  • NLSP 2021
  • ILAG 2022
  • Fundamental
  • Price
  • NLSP $2.86
  • ILAG $0.50
  • Analyst Decision
  • NLSP
  • ILAG
  • Analyst Count
  • NLSP 0
  • ILAG 0
  • Target Price
  • NLSP N/A
  • ILAG N/A
  • AVG Volume (30 Days)
  • NLSP 365.2K
  • ILAG 556.1K
  • Earning Date
  • NLSP 07-07-2025
  • ILAG 07-07-2025
  • Dividend Yield
  • NLSP N/A
  • ILAG N/A
  • EPS Growth
  • NLSP N/A
  • ILAG N/A
  • EPS
  • NLSP N/A
  • ILAG N/A
  • Revenue
  • NLSP N/A
  • ILAG $7,506,551.00
  • Revenue This Year
  • NLSP N/A
  • ILAG N/A
  • Revenue Next Year
  • NLSP N/A
  • ILAG N/A
  • P/E Ratio
  • NLSP N/A
  • ILAG N/A
  • Revenue Growth
  • NLSP N/A
  • ILAG 16.50
  • 52 Week Low
  • NLSP $1.30
  • ILAG $0.34
  • 52 Week High
  • NLSP $15.59
  • ILAG $1.35
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 67.56
  • ILAG 51.82
  • Support Level
  • NLSP $2.19
  • ILAG $0.41
  • Resistance Level
  • NLSP $2.54
  • ILAG $0.56
  • Average True Range (ATR)
  • NLSP 0.19
  • ILAG 0.10
  • MACD
  • NLSP 0.02
  • ILAG -0.00
  • Stochastic Oscillator
  • NLSP 82.76
  • ILAG 26.15

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.

Share on Social Networks: